Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 99

1.

Prognostic value of subclassification (pT2 stage) of pathologically organ-confined prostate cancer: Confirmation of the changes introduced in the 8th edition of the American Joint Committee on Cancer (AJCC) staging system.

Antunes HP, Parada B, Carvalho J, Eliseu M, Jarimba R, Oliveira R, Tavares-da-Silva E, Figueiredo A.

Arch Ital Urol Androl. 2018 Sep 30;90(3):191-194. doi: 10.4081/aiua.2018.3.191.

2.

The prognostic role of the pathological T2 subclassification for prostate cancer in the 2002 Tumour-Nodes-Metastasis staging system.

van Oort IM, Witjes JA, Kok DE, Kiemeney LA, Hulsbergen-Van De Kaa CA.

BJU Int. 2008 Aug;102(4):438-41. doi: 10.1111/j.1464-410X.2008.07611.x. Epub 2008 Mar 11.

3.

Does Subclassification of Pathologically Organ Confined (pT2) Prostate Cancer Provide Prognostic Discrimination of Outcomes after Radical Prostatectomy?

Nguyen DP, Vertosick EA, Sharma V, Corradi RB, Vilaseca A, Takeda T, Sjoberg DD, Benfante N, Fine SW, Reuter VE, Scardino PT, Eastham JA, Karnes RJ, Touijer KA.

J Urol. 2018 Jun;199(6):1502-1509. doi: 10.1016/j.juro.2017.12.056. Epub 2018 Jan 4.

PMID:
29307681
5.

Evaluation of pT2 subdivisions in the TNM staging system for prostate cancer.

Hong SK, Han BK, Chung JS, Park DS, Jeong SJ, Byun SS, Choe G, Lee SE.

BJU Int. 2008 Nov;102(9):1092-6. doi: 10.1111/j.1464-410X.2008.07897.x. Epub 2008 Jul 29.

6.

Modification of the pT2 substage classification in prostate adenocarcinoma.

Ettel M, Kong M, Lee P, Zhou M, Melamed J, Deng FM.

Hum Pathol. 2016 Oct;56:57-63. doi: 10.1016/j.humpath.2016.05.016. Epub 2016 May 29.

PMID:
27251951
7.

The 2002 AJCC pT2 substages confer no prognostic information on the rate of biochemical recurrence after radical prostatectomy.

Chun FK, Briganti A, Lebeau T, Fradet V, Steuber T, Walz J, Schlomm T, Eichelberg C, Haese A, Erbersdobler A, McCormack M, Perrotte P, Graefen M, Huland H, Karakiewicz PI.

Eur Urol. 2006 Feb;49(2):273-8; discussion 278-9. Epub 2006 Jan 6.

PMID:
16413103
8.

Independent Validation of the American Joint Committee on Cancer 8th Edition Prostate Cancer Staging Classification.

Bhindi B, Karnes RJ, Rangel LJ, Mason RJ, Gettman MT, Frank I, Tollefson MK, Lin DW, Thompson RH, Boorjian SA.

J Urol. 2017 Dec;198(6):1286-1294. doi: 10.1016/j.juro.2017.06.085. Epub 2017 Jun 29.

PMID:
28669765
9.

Pathological stage T2 subgroups to predict biochemical recurrence after prostatectomy.

Kordan Y, Chang SS, Salem S, Cookson MS, Clark PE, Davis R, Herrell SD, Baumgartner R, Phillips S, Smith JA Jr, Barocas DA.

J Urol. 2009 Nov;182(5):2291-5. doi: 10.1016/j.juro.2009.07.020. Epub 2009 Sep 16.

PMID:
19758638
10.

Biochemical failure after radical prostatectomy in men with pathologic organ-confined disease: pT2a versus pT2b.

Freedland SJ, Partin AW, Epstein JI, Walsh PC.

Cancer. 2004 Apr 15;100(8):1646-9.

12.

Superficial (pT2a) and deep (pT2b) muscle invasion in pathological staging of bladder cancer following radical cystectomy.

Yu RJ, Stein JP, Cai J, Miranda G, Groshen S, Skinner DG.

J Urol. 2006 Aug;176(2):493-8; discussion 498-9.

PMID:
16813876
13.

Prognostic significance of tumor volume in radical prostatectomy and needle biopsy specimens.

Epstein JI.

J Urol. 2011 Sep;186(3):790-7. doi: 10.1016/j.juro.2011.02.2695. Epub 2011 Jul 23. Review.

PMID:
21788055
14.

Is subdivision of pT2 tumors superior to lymph node metastasis for predicting survival of patients with gastric cancer? Review of 224 patients from four centers.

Bilici A, Dane F, Seker M, Ustaalioglu BB, Aliustaoglu M, Temiz S, Gezen C, Yavuzer D, Aksu G, Mayadagli A, Gumus M, Uygun K, Turhal NS.

Dig Dis Sci. 2011 Nov;56(11):3226-34. doi: 10.1007/s10620-011-1721-z. Epub 2011 Jun 10.

PMID:
21660487
15.

Comparative assessment of the 1992 and 2002 pathologic T3 substages for the prediction of biochemical recurrence after radical prostatectomy.

Steuber T, Erbersdobler A, Graefen M, Haese A, Huland H, Karakiewicz PI.

Cancer. 2006 Feb 15;106(4):775-82.

16.

A novel subclassification of pT2 gastric cancers according to the depth of muscularis propria invasion: superficial muscularis propria versus deep muscularis propria/subserosa.

Sun Z, Zhu GL, Lu C, Guo PT, Huang BJ, Li K, Xu Y, Wang ZN, Xu HM.

Ann Surg. 2009 May;249(5):768-75. doi: 10.1097/SLA.0b013e3181a3df77.

PMID:
19387327
17.

Evaluation of the major changes in eighth edition of the American Joint Committee on Cancer pathological staging for prostate cancer treated with prostatectomy.

Xiao WJ, Zhu Y, Dai B, Ye DW.

PLoS One. 2017 Nov 9;12(11):e0187887. doi: 10.1371/journal.pone.0187887. eCollection 2017.

18.

Evaluation of Prostate Cancer Stage Groups Updated in the 8th Edition of the American Joint Committee on Cancer Tumor-Node-Metastasis Staging Manual.

Lee H, Lee M, Byun SS, Lee SE, Hong SK.

Clin Genitourin Cancer. 2018 Nov 1. pii: S1558-7673(18)30536-6. doi: 10.1016/j.clgc.2018.10.015. [Epub ahead of print]

PMID:
30472041
19.

Validation of American Joint Committee on Cancer eighth staging system among prostate cancer patients treated with radical prostatectomy.

Abdel-Rahman O.

Ther Adv Urol. 2017 Nov 8;10(2):35-42. doi: 10.1177/1756287217737706. eCollection 2018 Feb.

20.

Assessing the Optimal Timing for Early Salvage Radiation Therapy in Patients with Prostate-specific Antigen Rise After Radical Prostatectomy.

Fossati N, Karnes RJ, Cozzarini C, Fiorino C, Gandaglia G, Joniau S, Boorjian SA, Goldner G, Hinkelbein W, Haustermans K, Tombal B, Shariat S, Karakiewicz PI, Montorsi F, Van Poppel H, Wiegel T, Briganti A.

Eur Urol. 2016 Apr;69(4):728-733. doi: 10.1016/j.eururo.2015.10.009. Epub 2015 Oct 21.

PMID:
26497924

Supplemental Content

Support Center